In search of potent 5-HT6 receptor inverse agonists

Chemical Biology and Drug Design

Volumn 83, Issue 6, 2014, Pages 666-669

  Hostetler, Greg ^a   Dunn, Derek ^a   McKenna, Beth Ann ^a   Kopec, Karla ^a   Chatterjee, Sankar ^a  

^a CEPHALON INC   (United States)

Author keywords

benzazepine; CNS disorders

Indexed keywords

SEROTONIN 6 RECEPTOR; SEROTONIN 6 RECEPTOR INVERSE AGONIST; SEROTONIN AGONIST; UNCLASSIFIED DRUG; BENZAZEPINE DERIVATIVE; PROTEIN BINDING; SEROTONIN RECEPTOR; SULFONAMIDE; SULFONE;

ARTICLE; CHIRALITY; DEPROTECTION REACTION; DRUG POTENCY; DRUG STRUCTURE; ENANTIOMER; INVERSE AGONISM; PRIORITY JOURNAL; RECEPTOR BINDING ASSAY; STRUCTURE ACTIVITY RELATION; SUBSTITUTION REACTION; BIOASSAY; CHEMICAL STRUCTURE; CHEMISTRY; DRUG EFFECTS; HUMAN;

BENZAZEPINES; BIOLOGICAL ASSAY; DRUG INVERSE AGONISM; HUMANS; MOLECULAR STRUCTURE; PROTEIN BINDING; RECEPTORS, SEROTONIN; SULFONAMIDES; SULFONES;

EID: 84901044453     PISSN: 17470277     EISSN: 17470285     Source Type: Journal    
DOI: 10.1111/cbdd.12279     Document Type: Article

References (10)

1. Vitalis T., Ansorge M.S., Dayer A.G., (2013) Serotonin homeostasis and serotonin receptors as actors of cortical construction: special attention to the 5-HT3A and 5-HT6 receptor subtypes. Front Cell Neurosci; 7: 93.
2. Ramirez M.J., (2013) 5-HT6 receptors and Alzheimer's disease. Alzheimer's Res Ther; 5: 15. [epub ahead of print.]
3. Shimizu S., Mizuguchi Y., Ohno Y., (2013) Improving the treatment of schizophrenia: role of 5-HT receptors in modulating cognitive and extrapyramidal motor functions. CNS Neurol Disord Drug Targets; 12: 861-869
4. Wesołowska A., (2010) Potential role of the 5-HT6 receptor in depression and anxiety: an overview of clinical data. Pharmacol Rep; 62: 564-577.
5. Ly S., Pishadari B., Lok L.L., Hajos M., Kocsis B., (2013) Activation of 5-HT6 receptors modulates sleep-wake activity and hippocampal theta oscillation. ACS Chem Neurosci; 4: 191-199.
6. Marazziti D., Baroni S., Borsini F., Picchetti M., Falaschi V., Catena-Dell M.O., (2013) Serotonin receptors of type 6 (5-HT6): from neuroscience to clinical pharmacology. Curr Med Chem; 20: 371-377.
7. Rossé G., Schaffhauser H., (2010) 5-HT6 receptor antagonists as potential therapeutics for cognitive impairment. Curr Top Med Chem; 10: 207-221.
8. Maher-Edwards G., Zvartau-Hind J., Hunter A.J., Gold M., Hopton G., Jacobs G., Davy M., Williams P., (2010) Double-blind, controlled phase II study of a 5-HT6 receptor antagonist, SB-742457, in Alzheimer's disease. Curr Alzheimer Res; 7: 374-385.
9. Hostetler G., Dunn D., McKenna B.A., Kopec K., Chatterjee S., (2013) 1-Thia-4,7-diaza-spiro[4.4]nonane-3,6-dione: a structural motif for 5-hydroxytryptamine 6 receptor antagonism. Chem Bio Drug Des; 83: 149-153.
10. Bacon E.R., Bailey T.R., Dunn D.D., Hostetler G.A., McHugh R.J., Morton G.C., Rossé G.C., Salvino J.M., Sundar B.G., Tripathy R., (2011) Patent application WO 2011/087712:1-222.